In addition, a portion of the PTHR1-binding domain and midregion (amino acids 12–48) was identified in patient plasma samples via mass spectrometry as a potential biomarker for metastatic breast cancer, implying that fragmented PTHrP circulates in a breast cancer disease state [67]. Here, PTH1R is linked to breast carcinoma.